PATENT CLAIM ANALYSIS

Application Number: 15939837
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "294000"]

Abstract:
This invention relates to the use of combinations of stereoisomers of dihydrotetrabenazine for the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 2):
A pharmaceutical combination according to  claim 1  comprising:\n (a) (+)-\u03b2-dihydrotetrabenazine, or a pharmaceutically acceptable salt thereof; and \n (b) (\u2212)-\u03b1-dihydrotetrabenazine, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15939826', '12555695', '15044655', '15071797', '14030322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7228796632903259
- 35 USC 102 Novelty (BERT): 0.6464308723766304
- Combined Prediction Score: 0.7152347841989564
- Mean Citation Score: 358.154622
- Max Citation Score: 664.932
- Similarity Product: 553.8398083848954

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test